MRSA Extraction Workstation

06 Mar 2008
Share
Methicillin resistant Staphylococcus aureus (MRSA) has evolved an ability to survive treatment with beta-lactam antibiotics and is especially troublesome in hospital-associated infections. Consequently most hospitals screen samples from both patients and other possible contamination sources. These samples are first cultivated, then boiled and finally analysed by qPCR (quantitative polymerase chain reaction).

Xiril offers an optimal implementation of the DNA extraction on its highly accurate robotic workstations and allows a high throughput of samples with small input of time and manpower. This fully automated method allows the extraction of 96 samples within 50 minutes and enables a straightforward and cost-effective solution. Furthermore it offers the possibility to implement other actions such as the PCR setup without major investments. - Automation doesn’t have to be complicated.

Request Info


Company website

Xiril AG